Credibility, Trust and Conviction

Scientific leaders positioned as industry references. Innovations adopted faster. Lasting trust-based relationships with HCPs. This is what behavior engineering looks like in healthcare.

Trusted by leading companies

Medical congress calendar

Articles

Services

KOL Speaker Training

Communication and presentation skill development for key opinion leaders in the pharmaceutical industry.

Medical Affairs Communication

Integrated communication programs for medical affairs teams who need to articulate science with strategy.

Advisory Board Facilitation

Session structure and facilitation that maximizes scientific input and strengthens HCP relationships.

Scientific Presentation Design

Visual design and narrative principles applied to high-impact medical and scientific materials.

Pharma Sales Force

Communication and storytelling for commercial teams who need to build trust with HCPs.

FAQ

What is Behavior Engineering applied to the pharmaceutical industry?

It is a methodology that designs and measures behavior changes in healthcare professionals: from how a KOL presents scientific evidence to how a commercial team communicates value without relying on discounts.

What type of training do you offer for KOLs?

Speaker Training programs that develop communication, scientific presentation and personal branding skills for key opinion leaders. Includes preparation for medical congresses, advisory boards and internal presentations.

How does Advisory Board facilitation work?

We design the session structure, facilitate the conversation to maximize scientific input from experts and deliver an actionable insights report for the Medical Affairs team.

Does the training comply with NOM-220-SSA1-2016 pharmacovigilance requirements?

Our scientific communication programs are designed to operate within the Mexican regulatory framework, including NOM-220 pharmacovigilance obligations and NOM-059 good manufacturing practices.

Does Plan México allow corporate training tax deductions?

Yes. The Plan México 2025-2030 fiscal stimulus decree grants an additional 25% deduction on increases in employee training spending, applicable to pharmaceutical companies.

Get started

Ready to take the first step?